Efficacy of ChemoID® guided drug selection for palliative chemotherapy in advanced recurrent high-grade ovarian adenocarcinoma: Case study

Notwithstanding tremendous advances in surgery, primary chemotherapy, and novel treatments for recurrent disease, the diagnosis of advanced epithelial ovarian cancer (EOC) in 2016 remains ultimately fatal in the majority of cases. Advanced therapy refractory EOC patients are often treated in hospice...

Full description

Saved in:
Bibliographic Details
Published inTranslational Medicine Reports Vol. 2; no. 1
Main Authors DeEulis, Timothy G., Howard, Candace M., Valluri, Jagan, Claudio, Pier Paolo
Format Journal Article
LanguageEnglish
Published 13.10.2017
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first